Medtronic has received FDA clearance for its LigaSure RAS Maryland instrument for use with the Hugo robotic-assisted surgery (RAS) system in the US.
The clearance expands the range of instruments available for the Hugo platform and brings Medtronic’s LigaSure vessel-sealing technology to robotic-assisted procedures.
The instrument is designed to seal and cut vessels, thick tissue and lymphatics up to 7 mm in diameter.
Compatible with the Valleylab FT10 energy platform, the LigaSure RAS Maryland can seal vessels in approximately two seconds while helping to limit heat spread to nearby tissue.
According to Medtronic, the LigaSure technology has been used in more than 45 million procedures across over 65 countries during the past two decades.
The Hugo RAS system is currently cleared in the US for urological procedures.
Medtronic is also working to expand its indications to other soft-tissue procedures, including general and gynaecological surgery.
Outside the US, the Hugo system is commercially available in more than 35 countries and has been used in urology, general surgery and gynaecology.
The LigaSure RAS Maryland instrument was introduced for the Hugo platform in Europe in 2025 following CE Mark approval.
The latest FDA clearance expands the options available to surgeons using the robotic system.
